Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Active Drug/Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of ASKC200 in Patients With Knee Osteoarthritis Pain

NCT07742852 is registered in ClinicalTrials.gov with Jiangsu Aosaikang Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07742852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07742852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Active Drug/Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of ASKC200 in Patients With Knee Osteoarthritis Pain
Lead sponsor
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 12, 2025
Completion date
September 30, 2026
Enrollment
175 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis (oa) of the knee, pain